MILWAUKEE--(BUSINESS WIRE)--The Badger Meter, Inc. (NYSE:BMI) Board of Directors today declared a regular quarterly cash dividend of $0.34 per share to shareholders of record on May 23, 2025, payable
BMI's Q1 2025 performance is powered by the continued adoption of its digital water solutions and synergy from the SmartCover acquisition.
Badger Meter, Inc. (NYSE:BMI ) Q1 2025 Earnings Conference Call April 17, 2025 11:00 AM ET Company Participants Karen Bauer - Vice President, Investor Relations, Corporate Strategy and Treasurer Kenne
The increasing adoption of industrial automation, focus on higher energy efficiency and optimum resource utilization should drive the Zacks Instruments ??? Control industry.
Badger Meter (BMI) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $0.99 per share a year ago.
MILWAUKEE--(BUSINESS WIRE)--Badger Meter, Inc. (NYSE: BMI) today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Total sales of $222.2 million, 13% higher th
Growth is driven by the need for operational efficiencies amidst limited budgets of domestic water utilities bound by diverse regulations. Smart meters help mitigate Non-Revenue Water (NRW), which glo
Proposed site could accelerate time to market and revitalize existing infrastructure Companies aim to leverage BMI's critical minerals infrastructure and Northern's first mover advantage as North Amer
BMI's performance is likely to have benefited from demand for its solutions. However, the uncertain macro backdrop, higher costs and competition are concerns.
Badger Meter (BMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
In the most recent trading session, Badger Meter (BMI) closed at $172.87, indicating a +0.06% shift from the previous trading day.
-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p
Most investors will see Wall Street analysts take a new view on the stock and move past it, only weighing how much upside there could be in that specific pick. However, the true benefit of following a
Badger Meter (BMI) concluded the recent trading session at $192.67, signifying a +1.27% move from its prior day's close.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE